With a market that’s expected to grow from $2 billion in 2020 to $50 billion in only nine years, according to Statista, biotechnology companies are increasingly focused on the development of proprietary systems and procedures to drive research and production of cannabinoid pharmaceuticals.
MTRAC enables cannabis suppliers and their customers to complete transactions in a non-cash environment.
As one of Canada’s first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities.
With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
For 17 years Canada has provided legal access to medical cannabis to its citizens, and now the country is expected to legalize recreational marijuana by July 2018.
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC.
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
